GlassScriptPhysician profile
Joseph Wendolowski
NPI 1982610010
$5,249.77
in general payments reported to CMS, 2019-2025
20 companies · $234 in 2025
The $234 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,559 · 2020: $1,239 · 2021: $1,914 · 2022: $138 · 2023: $134 · 2024: $32.39 · 2025: $234.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $400.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $400.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supreme Orthopedic Systems, LLC | $1,402.03 | 2020-2024 | |
| Arthrex, INC. | $1,368.84 | 2021 | |
| Wright Medical Technology, INC. | $1,237.61 | 2019 | |
| Stryker Corporation | $229.97 | 2019-2020 | |
| Grt US Holding, INC. | $138.24 | 2022 | |
| Janssen Pharmaceuticals, INC | $121.80 | 2020 | |
| Amgen INC. | $114.00 | 2019 | |
| Lilly USA, LLC | $111.36 | 2021 | |
| Medtronic, INC. | $93.64 | 2025 | Endurant Iis |
| Globus Medical, INC. | $78.48 | 2025 | Senza |
| Integra Lifesciences Corporation | $73.88 | 2019-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Nevro Corp. | $52.22 | 2023-2024 | Senza |
| Organogenesis INC. | $48.68 | 2019-2025 | Via Matrix |
| Smith+Nephew, INC. | $42.92 | 2020-2025 | Collagenase Santyl |
| Averitas Pharma INC. | $37.68 | 2023 | Qutenza |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $32.12 | 2023 | |
| Convatec INC. | $21.09 | 2019 | |
| Tactile Systems Technology INC | $15.87 | 2023 | Flexitouch Plus, Entre Plus |
| Abbott Laboratories | $14.80 | 2023 | Proclaim |
| Zimmer Biomet Holdings, INC. | $14.54 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Wendolowski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.